𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antisense oligonucleotides for matrilysin inhibit proliferation of human rectal carcinoma cells CaR-1

✍ Scribed by N Momiyama; T Ishikawa; Y Ichikawa; H Yamaoka; Y Nagashima; K Miyazaki; M Mitsuhashi; H Shimada

Book ID
118880045
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
171 KB
Volume
108
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibition of cell proliferation and glu
Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1
✍ Shui-Hong Zhou; Jun Fan; Xiao-Ming Chen; Ke-Jia Cheng; Shen-Qing Wang πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 464 KB πŸ‘ 1 views

## Abstract ## Background. Malignant cells show increased glucose uptake in vitro and in vivo, which is thought to be mediated by glucose transporters. In this study, we investigated the effect of plasmid‐derived antisense RNA against the Glut‐l gene on proliferation and glucose uptake in laryngea

Matrilysin-specific antisense oligonucle
Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model
✍ Satoshi Hasegawa; Naohiko Koshikawa; Nobuyoshi Momiyama; Kayano Moriyama; Yasush πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 165 KB πŸ‘ 2 views

Human colon cancer frequently develops liver metastasis. Matrilysin (MMP-7), the smallest member of the matrix metalloproteinase (MMP) family, is commonly produced by human colon carcinoma cells and has been suggested to be involved in the progression and metastasis of this type of cancer. In the pr

Inhibition of cell proliferation in huma
Inhibition of cell proliferation in human breast tumor cells by antisense oligonucleotides against facilitative glucose transporter 5
✍ K.K. Chan; Judy Y.W. Chan; Karen K.W. Chung; Kwok-Pui Fung πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 196 KB πŸ‘ 1 views

## Abstract In recent years, successful examples of antisense oligonucleotide (AS) therapy for genetic diseases have stimulated scientists to investigate its application on cancer diseases. AS can be used to down‐regulate the mRNA and protein expression by annealing to specific region of the target